Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2010
10/07/2010WO2010112962A1 Identification, optimization and use of cryptic hla-a24 epitopes for immunotherapy
10/07/2010WO2010112713A2 Novel proteasome-activating lightening peptides and compositions containing same
10/07/2010WO2010112712A2 Novel proteasome-activating anti-aging peptides and compositions containing same
10/07/2010WO2010112711A2 Novel proteasome-activating lightening peptides and compositions containing same
10/07/2010WO2010112710A2 Novel proteasome-activating anti-aging peptides and compositions containing same
10/07/2010WO2010112628A1 Use of peptides and methods for determining whether a plant has been subjected to frost
10/07/2010WO2010111910A1 Synthetic peptide and uses thereof
10/07/2010WO2010111842A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/07/2010WO2010111789A1 Inhibition of formation of advanced glycation endproducts
10/07/2010WO2010111737A1 Peptide and phosphopeptide synthesis via phosphate assisted ligation
10/07/2010WO2010072843A3 Use of a peptide derived from er-alpha for restoring sensitivity to antiestrogenic compounds in breast tumour cells
10/07/2010US20100256334 Peptide Aptamers Against Tenascin C
10/07/2010US20100256332 GLP-1 Fusion Peptides, Their Production and Use
10/07/2010US20100256330 Peptide-based compounds
10/07/2010US20100256074 Processes for preparing high purity aza cyclohexapeptides
10/07/2010US20100256055 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/07/2010US20100256048 Polypeptide compound
10/07/2010US20100256041 Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
10/07/2010US20100256040 Composition and method for treating viral infection
10/07/2010US20100255501 Method of identifying a mhc class i restricted t cell response
10/07/2010US20100255499 Compositions and methods for transport of molecules with enhanced release properties across biological barriers
10/07/2010US20100255472 Biomarkers for prostate cancer
10/07/2010US20100255038 Purified polypeptide comprising or consisting of a c-terminus msp1 antigen from plasmodium falciparum carrying a glycosyl-phosphatidyl-inositol group (gpi)
10/07/2010US20100255020 Method for inducing cytotoxic t-cells, cytotoxic t-cell inducers, and pharmaceutical compositions and vaccines employing them
10/07/2010US20100255011 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
10/07/2010US20100254994 Compositions and Methods for Binding or Inactivating Ghrelin
10/07/2010US20100254964 Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof
10/07/2010CA2757210A1 C6orf167 peptides and vaccines containing the same
10/07/2010CA2756864A1 Prophylactic or therapeutic agent for retinal disease and method for prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase)-inhibitory peptide, and use of the peptide
10/07/2010CA2756238A1 Identification, optimization and use of cryptic hla-a24 epitopes for immunotherapy
10/07/2010CA2749512A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and use thereof
10/06/2010EP2236514A1 Artificial peptide and use thereof
10/06/2010EP2236513A1 An improved purification process for lipopeptides
10/06/2010EP2236151A1 Melanocortin receptor ligands
10/06/2010EP2235175A1 Polypeptide-nucleic acid conjugates and uses thereof
10/06/2010EP2235042A1 New blood coagulation factor inhibitors
10/06/2010EP2234635A2 Rhoc-based immunotherapy
10/06/2010EP1551449B1 Reagents and methods for engaging unique clonotypic lymphocyte receptors
10/06/2010CN101855237A Peptide ligand directed drug delivery
10/06/2010CN101855236A Detection and quantitation of urine gelsolin
10/06/2010CN101854945A Ctl inducer composition
10/06/2010CN101851276A Preparation method and activity detection for antibacterial peptides
10/06/2010CN101851275A Dimerized peptide
10/06/2010CN101851274A Polypeptides for suppressing invasion of hepatitis C virus
10/06/2010CN101851273A Glaucocalyxin A derivative, preparation method and application thereof
10/06/2010CN101851272A Glaucocalyxin B, derivative, preparation method and application thereof
10/06/2010CN101851271A Glaucocalyxin D derivative, preparation method and application thereof
10/06/2010CN101851270A Polymyxin derivative and preparation method thereof
10/06/2010CN101220084B Production method of polyglycol modifying ferric iron deuterohemin short peptide compound
10/06/2010CN101113163B Hla-a24-restricted cancer antigen peptides
10/05/2010US7807780 Multi-component biological transport systems
10/05/2010US7807779 Salt with physiologically tolerated acid; resistant to enzymatic degradation; oral administration, tumor therapy
10/05/2010US7807778 Cysteine-containing peptide tag for site-specific conjugation of proteins
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807640 stimulate the formation and cycling of pre-beta high density lipoprotein-like particles and/or promote lipid transport and detoxification and inhibit osteoporosis; class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini; atherosclerosis
10/05/2010US7807172 Methods and compositions for detecting thyroglobulin in a biological sample
10/05/2010US7807141 Tooth pellicle-binding peptide; binding to oral cavity surfaces, teeth and gums
10/05/2010CA2369595C Conjugate having a cleavable linkage for use in a liposome
10/05/2010CA2298438C Synthetic antigen for the detection of antibodies immunoreactive with hiv virus
09/2010
09/30/2010WO2010111652A2 Branched amphipathic oligo-peptides that self-assemble into vesicles
09/30/2010WO2010111597A2 Immunodominant compositions and methods of use therefor
09/30/2010WO2010111516A2 Compositions and methods for inhibiting biofilms
09/30/2010WO2010110455A1 Polyion complex comprising hydrophobized polyamino acid and use of same
09/30/2010WO2010108637A1 Crystalline compound
09/30/2010WO2010059051A3 Rapid fret-based diagnosis of bacterial pathogen
09/30/2010US20100250600 Small Molecule Mimetics of Erythropoietin
09/30/2010US20100249371 Purification process for lipopeptides
09/30/2010US20100249370 Process for the production of pramlintide
09/30/2010US20100249038 Antagonists of the receptor for advanced glycation end-products (rage)
09/30/2010US20100249035 Peptides, compositions and uses thereof
09/30/2010US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses
09/30/2010US20100249018 Composition and method for preventing and treating immune-related disorder
09/30/2010US20100248255 Novel peptides
09/30/2010US20100247618 Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
09/30/2010US20100247589 Peptide compositions for oral care systems
09/30/2010US20100247559 West nile virus vaccine, and method for production thereof
09/30/2010US20100247558 PEPTIDES INDUCING A CD4i CONFORMATION IN HIV gp120 WHILE RETAINING VACANT CD4 BINDING SITE
09/30/2010US20100247522 Linked purine pterin hppk inhibitors useful as antibacterial agents
09/30/2010US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds
09/30/2010US20100247457 Peptide-based tooth whitening reagents
09/30/2010DE102009012640A1 Mit einer Phosphoamidatgruppe modifizierte Verbindung und deren Verwendung With a Phosphoamidatgruppe modified compound and use thereof
09/29/2010EP2233571A1 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same
09/29/2010EP2231695A1 Antitumoral compounds
09/29/2010EP2231694A1 Cationic core-shell peptide nanoparticles
09/29/2010EP1692159B1 Tgf-beta1 binding and supported peptides
09/29/2010CN1865282B Solid phase polypeptide synthesis preparation method for terlipressin
09/29/2010CN1858060B Process for preparing solid phase polypeptide synthetic eptifibatide
09/29/2010CN101848937A Molecules and methods for modulating complement component
09/29/2010CN101848934A Neuroprotection using NAP-like and SAL-like peptide mimetics
09/29/2010CN101848932A Peptide having hypotensive activity
09/29/2010CN101848927A Analgesic compounds
09/29/2010CN101848926A Peptide capable of binding to immunoglobulin
09/29/2010CN101845091A Metastin derivatives and use thereof
09/29/2010CN101845081A Cyclic hexapeptide antibacterial compound
09/29/2010CN101845080A Angiotensin converting enzyme inhibitory peptide and preparation method thereof
09/29/2010CN101845079A Hexapeptide or derivative thereof and medical application thereof
09/29/2010CN101318992B Complete-basic amino acid oligopeptide, copper complex, synthesis method, self-assembly and application thereof
09/29/2010CN101085809B Synthetic and preparing technique for Batifeiban and analogue
09/29/2010CN101041687B PGE2 differential combined phage lambda ring seven peptide and sifting method and usage of synthesized peptide
09/28/2010US7803923 Growth differentiation factor-8 binding agents for treatment of metabolic, nervous system, muscular, bone , urogenital and inflammatory disorders; for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity
1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 423